rxstat › Shortages › Apixaban

Apixaban shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Apixaban has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 10
Reports on file
29

Reports by product

Resolved
SANDOZ APIXABAN SDZ
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489236 · ended Mar 23, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ APIXABAN SDZ
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489236 · ended Mar 20, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ APIXABAN SDZ
2.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489228 · ended Feb 2, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
TARO-APIXABAN
5MG · TABLET · SUN PHARMA CANADA INC
DIN 02510472 · ended Jan 21, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ APIXABAN SDZ
2.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489228 · ended Jan 8, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ APIXABAN SDZ
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489236 · ended Dec 12, 2025 · Disruption of the manufacture of the drug.
Resolved
ACH-APIXABAN
5MG · TABLET · ACCORD HEALTHCARE INC
DIN 02487721 · ended Nov 27, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
ACH-APIXABAN
5MG · TABLET · ACCORD HEALTHCARE INC
DIN 02487721 · ended Nov 21, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
ACH-APIXABAN
2.5MG · TABLET · ACCORD HEALTHCARE INC
DIN 02487713 · ended Nov 21, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
M-APIXABAN
5MG · TABLET · MANTRA PHARMA INC
DIN 02529017 · ended Aug 25, 2025 · Delay in shipping of the drug.
Resolved
TARO-APIXABAN
5MG · TABLET · SUN PHARMA CANADA INC
DIN 02510472 · ended Aug 12, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-APIXABAN
5MG · TABLET · SUN PHARMA CANADA INC
DIN 02510472 · ended Apr 10, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 29 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Apixaban. Health Canada has 29 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Apixaban is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AF).

Recent changes

Common questions

When will Apixaban be back in stock in Canada?

Apixaban has no active shortage; supply is normal per Health Canada reports.

Why is Apixaban in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antithrombotic agents)

Widespread shortageNadroparin7 of 8 reported products affectedWidespread shortageTicagrelor2 of 4 reported products affected · est. return Jul 31, 2026Partial shortageBivalirudin1 of 3 reported products affected · est. return Jun 30, 2026Partial shortageClopidogrel4 of 18 reported products affected · est. return Nov 10, 2026Partial shortageDabigatran Etexilate2 of 6 reported products affected · est. return Jun 12, 2026Partial shortageEdoxaban1 of 6 reported products affected · est. return Jul 10, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.